Journal of Dermatological Treatment · 2017 · 30 citations · 17 references
MedicineDermatologyPharmacotherapyClinical PharmacologyDermatopathologyOrofacial PainDrug-induced Skin ReactionsSkin IrritationAntihypertensive TreatmentCutaneous Reactions ManagementMedication-induced ErythemaPatient-reported Skin SymptomsRetrospective Case StudySkin Erythema
BACKGROUND: The treatment of persistent erythema and flushing episodes in patients with rosacea remains a clinical challenge. A possible therapeutic option could be the use of antihypertensive drugs. OBJECTIVES: We therefore evaluated the effect of the non-selective β-blocker carvedilol in five Caucasian patients. METHODS: In a monocentric retrospective case study, the patients were treated with carvedilol titrated up to 12.5 mg twice a day over at least six months. Patients self assessment (PSA), clinicians erythema assessment (CEA), and the patients levels of embarrassment and satisfaction were performed by questionaires. RESULTS: The CEA grade description as well as the PSA grade description decreased remarkably in all five patients. Furthermore, all patients reported to have a major improvement of their level of satisfaction and no feelings of embarrassment anymore. CONCLUSIONS: These findings demonstrate that facial flushing and persistent erythema can be effectively treated by carvedilol long-term with a fast onset of improvement in a dose well tolerated.
17
Jerry Tan, Luiz Maurício Costa Almeida, Anthony Bewley et al. · British Journal of Dermatology · 2016 · 280 citations · Full text
Medicine, Dermatology, Ophthalmology +10
Joseph F. Fowler, Michael Jarratt, Angela Moore et al. · British Journal of Dermatology · 2011 · 166 citations · Full text
Pharmacy, Dermatology, Pharmacology +14